Infectious Diseases Conferences | Infectious Diseases Congress 2026 | Iris Infectious Diseases Congress

Second Round Abstract Submission Ends on February 12, 2026 Mid Term Registration Closes on February 13, 2026

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

welcome message

Dear Colleagues, Partners and Friends,

On behalf of the Organizing Committee, it is my genuine pleasure to address this Welcome Message to the Infectious Diseases Congress (IDC 2026) which is scheduled to perform in Paris as an academic, scientific, artistic and intellectual Capital of the World.

Infectious diseases represent an old paradigm but the upgraded future in the devel-opment of OMICS-based and IT-driven innovations to the development of next-generation diagnostic, predictive, prognostic, therapeutic, preventive and prophy-lactic tools in Personalized and Precision Medicine (PPM). In this context, this Event would stimulate an enhanced understanding to surmount the obstacles to the creation of effective personalized drugs as well as precision diagnostic tools to pro-tect against pathogens, and would disclose clinically relevant biomarkers of predic-tive diagnostics, protection, prevention and treatment, and vaccine response hetero-geneity.

IDC 2026 | Hybrid Event

Iris Scientific Group LLC is excited to announce the upcoming "Infectious Diseases Congress (IDC 2026)", set against the backdrop of Paris, a dynamic hub of innovation and culture. Scheduled from April 23-25, 2026, this conference promises an engaging and enlightening experience for attendees and contributors alike.

Recognizing the evolving global landscape, IDC 2026 is designed as a Hybrid Event, allowing participants to engage either in-person at Paris, France or Virtually, ensuring accessibility to a worldwide audience. The conference theme, "Harnessing Digital Health: Innovations in Infectious Disease Surveillance and Management," underscores our commitment to exploring transformative digital technologies in disease prevention and control. Understanding infectious diseases is pivotal for developing effective strategies in prevention, treatment, and control. Research in this field is crucial for advancing medical science, safeguarding public health, and tackling global health challenges. IDC 2026 provides a crucial platform for interdisciplinary professionals to exchange ideas, share insights, and collaborate on cutting-edge research that impacts global health outcomes.

Join us at IDC 2026 as we navigate the forefront of infectious disease management. Whether you join us in-person or virtually, we invite you to contribute to shaping the future of healthcare. Save the dates and stay tuned for more details as we embark on this transformative journey towards advancing knowledge and addressing challenges in infectious diseases.

Conference Dates

April 23-25, 2026

Conference Venue

   Hotel CIS Paris Ravel
6 Av. Maurice Ravel, 75012
Paris, France  

Quick Links

Scientific Sessions

Infectious Disease Surveillance and Epidemiology

Effective surveillance and epidemiologic analysis are central to controlling the spread of infectious agents. This session emphasizes the application of Infectious Diseases, Epidemiology & Public Health, and Disease Prevention & Control in establishing robust monitoring systems. Participants will explore advanced epidemiologic tools, real-time data analytics, and outbreak detection methodologies. The discussion will include the integration of global and local reporting networks to provide timely, actionable insights for public health decision-making.

Participants will also examine the contribution of Vaccines and Immunization programs in reducing disease incidence, alongside methods for monitoring vaccine efficacy and coverage. Case studies will highlight successful strategies for mitigating disease outbreaks through proactive surveillance and data-driven interventions. Attendees will gain knowledge to design and implement epidemiological frameworks that optimize health outcomes and guide evidence-based policymaking.

Key Highlights

Advanced infectious disease surveillance methodologies
Epidemiologic modeling and outbreak forecasting
Data-driven strategies for public health interventions
Monitoring vaccine impact and coverage
Integration of global and local health networks

Why This Session Is Important?

Robust surveillance is essential for early outbreak detection and response. This session provides actionable insights for epidemiologists, clinicians, and public health professionals to strengthen disease monitoring systems and improve population health outcomes.

→

COVID 19 and Other Coronaviruses

The COVID-19 pandemic has reshaped the global approach to Infectious Diseases, highlighting the critical role of Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session explores SARS-CoV-2 alongside other coronaviruses, examining viral evolution, transmission patterns, and the effectiveness of containment measures. Participants will analyze case studies from diverse regions to understand outbreak management, policy interventions, and the integration of real-time data for epidemic forecasting.

Further discussion will cover the challenges of vaccine deployment, public health communication, and combating misinformation. Participants will explore Antimicrobial Resistance (AMR) implications in the context of secondary infections during viral outbreaks and strategies to maintain effective infection control. Attendees will gain insights into coordinated public health responses, evidence-based vaccination programs, and proactive measures to mitigate future coronavirus-related threats.

Key Highlights

Coronavirus epidemiology and outbreak trends
Vaccine implementation and booster strategies
Antimicrobial resistance considerations during viral outbreaks
Public health communication and disease control measures
Policy frameworks for pandemic preparedness

Why This Session Is Important?

Understanding coronaviruses is essential to prepare for current and future pandemics. This session equips healthcare professionals, researchers, and policymakers with tools to respond effectively and safeguard public health.

→

HIV/AIDS Research and Treatment Advances

HIV/AIDS continues to be a significant global health challenge, necessitating advanced strategies in Infectious Diseases, Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session covers the latest in antiretroviral therapy, breakthrough research in vaccine development, and innovative prevention programs. Participants will explore the global burden of HIV, emerging trends in high-risk populations, and evidence-based approaches to reduce transmission.

The session also highlights the role of Antimicrobial Resistance (AMR) in co-infections among HIV patients, addressing treatment challenges and public health implications. By combining research insights with practical public health interventions, attendees will learn to implement holistic strategies that optimize patient outcomes, prevent new infections, and strengthen community health programs.

Key Highlights

Advances in antiretroviral therapy and clinical management
HIV vaccine research and preventive strategies
Integration of epidemiology and public health approaches
Addressing antimicrobial resistance in co-infections
Community-based disease prevention and care programs

Why This Session Is Important?

Staying abreast of HIV/AIDS research is critical for reducing transmission and improving patient outcomes. This session equips participants with strategies to enhance treatment, prevention, and public health impact globally.

→

STD and HIV Infection

Sexually transmitted infections, including HIV, remain a critical component of Infectious Diseases, requiring focused Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization strategies. Participants will examine current trends, high-risk populations, and innovative interventions to reduce transmission. The session emphasizes evidence-based approaches to diagnostics, treatment, and preventive education, integrating lessons from community outreach and public health campaigns.

Antimicrobial Resistance (AMR) poses additional challenges in the treatment of bacterial STDs, highlighting the need for vigilant monitoring and responsible prescribing. Attendees will explore best practices for combining clinical care with public health strategies to reduce disease burden, implement preventive measures, and support health equity in diverse populations.

Key Highlights

Epidemiology and clinical management of STDs
Vaccine development for preventable infections
Public health and educational interventions
Addressing antimicrobial resistance in STD treatment
Community outreach and prevention strategies

Why This Session Is Important?

Effective management of STDs is essential to prevent long-term health complications and transmission. This session equips healthcare providers and public health professionals with tools to implement prevention, treatment, and education initiatives.

→

Ebola, Zika, and Other Viral Infections

Ebola, Zika, and other viral infections remain high-priority threats in Infectious Diseases, demanding attention to Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session examines the virology, transmission mechanisms, and clinical manifestations of emerging viral pathogens. Participants will explore rapid diagnostic tools, outbreak surveillance techniques, and strategies to strengthen community-level response systems. Real-world case studies illustrate successful containment and mitigation efforts, emphasizing lessons for global preparedness.

The session also highlights challenges posed by Antimicrobial Resistance (AMR) in co-infections during viral outbreaks and explores the integration of vaccination programs to reduce disease burden. Attendees will gain insights into designing evidence-based interventions, improving patient outcomes, and coordinating multi-level public health strategies that enhance preparedness and resilience against viral epidemics.

Key Highlights

Viral pathogen epidemiology and clinical management
Rapid diagnostics and outbreak surveillance
Vaccine deployment and immunization strategies
Addressing antimicrobial resistance in co-infections
Public health response frameworks and community preparedness

Why This Session Is Important?

Emerging viral infections pose global health risks. This session equips healthcare professionals and policymakers with the knowledge to anticipate outbreaks, implement effective interventions, and protect vulnerable populations.

→

Infectious Diseases Prevention, Control and Cure

Effective prevention and control of infectious agents are central to reducing morbidity and mortality worldwide. This session integrates Infectious Diseases, Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization approaches to explore strategies for minimizing the spread of pathogens. Participants will examine hygiene, sterilization, and vaccination protocols, alongside outbreak containment measures in healthcare and community settings. Case studies highlight successes in reducing disease transmission through evidence-based interventions.

The session further emphasizes Antimicrobial Resistance (AMR) management, including rational prescribing practices, stewardship programs, and global initiatives to curb resistant pathogens. Attendees will gain practical knowledge for implementing integrated prevention strategies that combine clinical care, public health initiatives, and community engagement to improve overall population health.

Key Highlights

Infection control and hygiene protocols
Vaccination programs and immunization strategies
Disease prevention campaigns and community engagement
Antimicrobial resistance management
Evidence-based outbreak control and containment

Why This Session Is Important?

Preventing infectious diseases is more effective than treatment alone. This session equips professionals with actionable strategies to reduce transmission, improve patient outcomes, and safeguard public health.

→

Human Papillomavirus (HPV) and Oncogenic Viruses

HPV and other oncogenic viruses present significant challenges in Infectious Diseases, requiring focused attention on Epidemiology & Public Health, Disease Prevention & Control, and Vaccines and Immunization. This session examines the global burden of HPV, modes of transmission, and risk factors contributing to cervical and other cancers. Participants will explore vaccination strategies, screening programs, and early intervention protocols that reduce disease incidence and improve patient outcomes.

The session also considers Antimicrobial Resistance (AMR) in the context of co-infections and secondary bacterial complications, highlighting evidence-based approaches to prevention and treatment. By integrating public health policies with clinical care, attendees will gain insights into comprehensive strategies for reducing HPV-related disease and improving population health.

Key Highlights

HPV epidemiology and oncogenic virus surveillance
Vaccine implementation and immunization strategies
Early detection and screening programs
Antimicrobial resistance considerations
Public health outreach and education

Why This Session Is Important?

Reducing HPV and oncogenic viral infections prevents cancer and improves public health outcomes. This session equips healthcare professionals with actionable strategies for prevention, screening, and vaccination programs.

→

Streptococcal and Staphylococcal Infections

Streptococcal and staphylococcal infections continue to cause significant morbidity and mortality in Infectious Diseases, emphasizing Epidemiology & Public Health, Disease Prevention & Control, and the role of Vaccines and Immunization where applicable. Participants will explore transmission dynamics, risk populations, and the latest evidence-based clinical interventions to reduce infection rates.

The session also addresses Antimicrobial Resistance (AMR) challenges and strategies to optimize antibiotic use, including stewardship programs and treatment guidelines. Attendees will gain practical insights for integrating clinical care with public health initiatives to minimize outbreaks, improve patient outcomes, and implement effective infection control measures.

Key Highlights

Bacterial pathogen epidemiology and clinical management
Antibiotic stewardship and AMR mitigation
Prevention strategies in healthcare and community settings
Patient education and public health interventions
Evidence-based treatment protocols

Why This Session Is Important?

Managing streptococcal and staphylococcal infections is vital for reducing disease burden. This session provides strategies to optimize treatment, prevent transmission, and protect population health.

→

View All Scientific Sessions

Scientific Committee

Alexey Severtsev

Pirogov Russian National Research Medical University, Russian Federation

Pierre A. Morgon

MRGN Advisors, MRGN Advisors

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Jacques Demongeot

University Hospital of Grenoble, France

View All Committee Members

Speakers

Morad Sallam

St Thomas NHS Foundation Trust, United Kingdom

Siham Mahgoub

Howard University, United States

Sasha Leibholz

New York Presbyterian Columbia, United States

Lauren Gruffi

New York Presbyterian Columbia, United States

Michaela Greenlee

Harvard School of Public Health, United States

Ayra Ali

Howard University, United States

Mariano Votta

Active Citizenship Network, Italy

Fawzy Abdelatty

Heidelberger Center for Cellular Therapy, Germany

Sen Zhang

Huazhong Agricultural University, China

Pei Fang Liu

National Taiwan University Hospital, Taiwan

Carla Sofia Ramos Alves Sirage

University of Lisbon, Portugal

Hanen Ben Amor Chelbi

Pasteur Institute of Tunis, Tunisia

Vladimir Zajac

Cancer Research Institute, Slovakia

Rachel Si Yin Wong

National University of Singapore, Singapore

Manish Tripathi

Break Out Session

Brochure Download

Name:

Email:

Phone:

Select Country:

Your Message

Enter CAPTCHA:

Reload

Past Conference Information

Iris Scientific Group takes great pride in announcing the successful outcome of the World Health Care and Nursing Conference (WHCN 2019) which was held in Valencia, Spain from September 23-25, 2019.

For WHCN 2019 Final Program: Click here

For WHCN 2019 Proceedings: Click Here

For WHCN 2019 Gallery: Click Here

In 2019 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.

Organizing Committee of WHCN 2019:

Pirkko Kouri, Savonia University of Applied Sciences, Finland
Penny Daugherty, Northside Hospital Cancer Institute, USA
Maria Rosaria Mascolo, University of Genoa, Italy
Carol A Conley, Boston Medical Center, USA

The Organizing Committee would like to thank the moderators Angela O'Connor, King Edward Memorial Hospital, Australia, and Carrinna A. Hansen, University of Copenhagen, Denmark for their contribution which ensued in the smooth functioning of the conference.

Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.

Nursing Conference 2019 Keynote Speakers:

Pirkko Kouri, Savonia University of Applied Sciences Ltd, Finland
Liisa Kathleen Ortegon, Houston Methodist Hospital, USA
Penny Daugherty, Northside Hospital Cancer Institute, USA

Nursing Conference Speakers:

Renee B Bazzelle, USA Navy Nurse Corps, USA
Susanne Salmela, Vaasa Central Hospital, Finland
Noël Busch-Armendariz, The University of Texas at Austin, USA
Margaret Bassett, The University of Texas at Austin, USA
Deidi Olaya-Rodriguez, Washington University in St. Louis, USA
Donna Rolin, The University of Texas at Austin, USA
Shirley Evers-Manly, All Health Care/Imani’s, USA
Elvessa Narvasa, Canadian Council of Cardiovascular Nurses, Canada
Eugenia Trigoso Arjona, Hospital Universitario y Politécnico LA FE, Spain
Sonia Casanova Vivas, Health Public Department, Spain
Elena Baixauli Gallego, University of Valencia, Spain
Arda Teunissen, Spitex Zürich Limmat, Switzerland
Angela O'Connor, King Edward Memorial Hospital, Australia
Soy Ramsumeer, Comprehensive T2DM Services and A-Z Diabetes & Wound Care Services, USA
Pete Nathans, Comprehensive T2DM Services and A-Z Diabetes & Wound Care Services, USA
Carrinna A. Hansen, University of Copenhagen, Denmark
Krista L. Nelson, Southern Arkansas University, USA
Jana Slobodníková, Alexander Dubcek University of Tren?ín, Slovakia
Elaine Clear, St Vincent’s University Hospital, Ireland
Farooq Brohi, North Tees & Hartlepool NHS Foundation Trust, UK
Revue Eric, Lariboisière Hospital, France
Nojoud Alreshidi, University of Hail, Saudi Arabia
Nayara Perla Silva, Government of the state of Pernambuco, Brazil
Lubinu Francesco, CPS Lugano, Switzerland
Tiina Arpola, Savonia University of Applied Sciences, Finland
Hanna-Mari Nevala, Savonia University of Applied Sciences, Finland
Mona Taylor, Thompson Rivers University, Canada
Margaret C. Maimbolwa, University of Zambia, Zambia
Zhenhua SANG, Beijing Tsinghua Chang Gung Hospital, China
Pei-Shan Lee, Linkou Chang Gung Memorial Hospital, Taiwan
Shui-Tao Hu, Chang Gung Memorial Hospital, Taiwan
Juan Cai, Beijing Tsinghua Changgung Hospital, China
Chuan Yun-Zhang, Beijing Tsinghua Changgung Hospital, China
Jantakan Kanjanawetang, Suranaree University of Technology, Thailand
Joanna Chyliska, Medical University of Warsaw, Poland

Nursing Conference 2019 Workshops:

Workshop on: Interprofessional education and its integration into a nursing curriculum

Cynthia Horton, Cecil College, USA

Workshop on: Hospital offers living lab platform to advance nursing

Merita Kaunisto, Kuopio University Hospital, Finland

Hanna-Mari Nevala, Savonia University of Applied Sciences, Finland

Tiina Arpola, Savonia University of Applied Sciences, Finland

Nursing Conference 2019 Poster Presenters:

Chantira Chiaranai, Suranaree University of Technology, Thailand
Warithorn Prawatwong, Suranaree University of Technology, Thailand
Saranya Chularee, Suranaree University of Technology, Thailand
Mi-Chun Chou, Chang Gung Memorial Hospital, Taiwan
Tzu-Ting Chen, Chang Gung Memorial Hospital, Taiwan
Li hua Cheng, Chang Gung Memorial Hospital, Taiwan
Pei-Chien Lu, Chang Gung Memorial Hospital, Taiwan
Soy Ramsumeer, Comprehensive T2DM Services and A-Z Diabetes & Wound Care Services, USA
Pete Nathans, Comprehensive T2DM Services and A-Z Diabetes & Wound Care Services, USA
Susan Berry Cann, St Elizabeth’s Medical Center, USA

We congratulate the Best poster award winner Chantira Chiaranai, Suranaree University of Technology, Thailand. We would also like to thank Cynthia Horton, Cecil College, USA who supported us by evaluating the posters.

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in "3rd International Nursing Networking Conference (INNC-2025)" during April 23-25, 2025, at Las Vegas, USA, and in Virtual format.

Iris Scientific Group takes great pride in announcing the successful outcome of the World Catalysis and Chemical Engineering Network Congress (WCCN 2025) which was held in Virtual Mode from April 23-25, 2025.

For WCCN 2025 Final Program: Click Here

In 2025 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.

Organizing Committee of WCCN 2025:

Dai-Yeun Jeong, Director of Asia Climate Change Education Center, South Korea
Thomas Webster, Hebei University of Technology, United States
Eleonora Aneggi, University of Udine, Italy
Maria Jose Lavorante, Institution of Scientific and Technological Research for Defense, Argentina
Tokeer Ahmad, Jamia Millia Islamia, India
Vasily Lutsyk, Buryat State University, Russia
Valery P. Kalinitchenko, Institute of Fertility of Soils of South Russia, Russia

The Organizing Committee would like to thank the moderators Maria Jose Lavorante, Institution of Scientific and Technological Research for Defense, Argentina and Rahul Hajare, Sandip University, India for their contribution which ensued in the smooth functioning of the conference.

WCCN 2025 Keynote Speakers:

Dai-Yeun Jeong, Director of Asia Climate Change Education Center, South Korea
Thomas Webster, Hebei University of Technology, United States
Eleonora Aneggi, University of Udine, Italy
Maria Jose Lavorante, Institution of Scientific and Technological Research for Defense, Argentina
Tokeer Ahmad, Jamia Millia Islamia, India
Vasily Lutsyk, Buryat State University, Russia
Valery P. Kalinitchenko, Institute of Fertility of Soils of South Russia, Russia

WCCN 2025 Plenary Speakers:

Alexander G. Ramm, Kansas State University, USA

WCCN 2025 Speakers:

Joanna Drzezdzon, University in GdaÅ„sk, Poland
Kumar Sachin, Taylors University, Malaysia
Rahul Hajare, Sandip University, India
Ashanendu Mandal, University of Calcutta, India
Omvir Singh, Rajiv Gandhi Institute of Petroleum Technology, India
Delia Teresa Sponza, Dokuz Eylul University, Turkey
Jose Angel Siles Lopez, University of Córdoba, Spain
Osman Adiguzel, Firat University, Turkey
Ðœikhail Kashchenko, Ural Federal University, Russia
Luis Isernia, University of Oriente, Venezuela
Orlando Elguera, National University of Engineering, Peru
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Ali Yetgin, Cukurova University, Turkey
Lazhar Hajji, University of Al Manar Tunis, Tunisia

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in “2nd World Catalysis and Chemical Engineering Network Congress (WCCN 2026)” during April 22-24, 2026. WCCN 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.

Iris Scientific Group takes great pride in announcing the successful outcome of the 3rd International Nursing Networking Conference (INNC 2025) which was held in Virtual Mode from April 23-25, 2025.

For INNC 2025 Final Program: Click Here

Organizing Committee of INNC 2025:

Sofica Bistriceanu, Academic Medical Unit - CMI, Romania
Bernd Blobel, University of Regensburg, Germany
Daryle Wane, Pasco-Hernando State College, United States
Petrova Nataliya, Saint Petersburg State I. P. Pavlov Medical University, Russian Federation

The Organizing Committee would like to thank the moderators Sofica Bistriceanu, Academic Medical Unit - CMI, Romania, and Anum Fatima, Chiang Mai University, Thailand for their contribution which ensued in the smooth functioning of the conference.

INNC 2025 Keynote Speakers:

Sofica Bistriceanu, Academic Medical Unit - CMI, Romania
Bernd Blobel, University of Regensburg, Germany
Daryle Wane, Pasco-Hernando State College, United States
Petrova Nataliya, Saint Petersburg State I. P. Pavlov Medical University, Russian Federation

INNC 2025 Speakers:

Neomie Congello, California State University Channel Islands, United States
Saumya Pandey, Indira IVF Hospital, India
Liangmei Chen, Xi'an Mental Health Center, China
Schaffer Daniela, Klagenfurt Hospital, Austria
Franz Porzsolt, Private Research Institute Clinical Economics, Germany
Melike Yavas Celik, Gaziantep University, Turkey
Kenneth R. Marileise Roberta Antoneli Fonseca, Universidade Estadual de Campinas (UNICAMP), Brazil
Juliet Ugbedeojo Shaibu, Global Health Policy Task Force, WFPHA, Switzerland
Anum Fatima, Chiang Mai University, Thailand
Ayan Chatterjee, Medhavi Skills University, India
David John Wortley, UK
Humna Baig, Al Rehaab, Pakistan
Mohammad Hossein Delshad, Torbat Heydariyeh University of Medical Sciences, Iran, Islamic Republic of
Mary Anbarasi Johnson, College of Nursing, India
Vanessa Williams Harvey, HippoCLIN, United States
Nonye Tochi Aghanya, United States
Yousef Ahmed Al shaabi, Sana, a University, Yemen
El moubchiri chaimaa, Hassan First University of Settat, Morocco

INNC 2025 Poster Presenters:

Ashley N. Frederick, Western Illinois University, United States
Dylan Salrin, Children's Hospital Colorado, United States
Hanan Morsy Salim Metwally, Zagazig University, Egypt
Lt Col Yamuna CB, Army & Delhi University, India

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in “4th International Nursing Networking Conference (INNC 2026)” during April 13-15, 2026. INNC 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.

Iris Scientific Group takes great pride in announcing the successful outcome of the International Cancer Conference (ICC 2025) which was held in Virtual Mode from November 27-29, 2025.

For ICC 2025 Final Program: Click Here

Organizing Committee of ICC 2025:

Orestis Ioannidis, Aristotle University of Thessaloniki, Greece
Jacques Pouyssegur, University of Nice, France
Manmohan Agarwal, Pushpadi Cancer Care Centre, India
Kye Young Lee, Konkuk University Medical Center, South Korea
Arezou Ghazani, Harvard Medical School, United States
Toshiko Kato, Independent researcher, Japan

The Organizing Committee would like to thank the moderators Don Mathew, Pacific Medical College & Hospital, India for his contribution which ensued in the smooth functioning of the conference.

ICC 2025 Keynote Speakers:

Orestis Ioannidis, Aristotle University of Thessaloniki, Greece
Jacques Pouyssegur, University of Nice, France
Manmohan Agarwal, Pushpadi Cancer Care Centre, India
Kye Young Lee, Konkuk University Medical Center, South Korea
Arezou Ghazani, Harvard Medical School, United States
Toshiko Kato, Independent researcher, Japan
Don Mathew, Pacific Medical College & Hospital, India
Homer S. Black, Baylor College of Medicine, United States

ICC 2025 Speakers:

Jun Bai, Shaanxi Provincial People’s Hosptital, China
Michael Firer, Ariel University, Israel
Manisha Lakhanpal Sharma, Consultant Emanate Dental Clinic, India
Mohite Utkarsha Laxman, MET's League of Colleges Bhujbal, India
Saad Sabbar Dahham, University of Technology and Applied Science, Oman
Emma Holly, Restore Therapy Ltd, United Kingdom
Lorenzo Andreani, Azienda Ospedaliero Universitaria Pisana, Italy
Nomeda Juodziukyniene, University of Health Sciences, Lithuania
Vladan Radosavljevic, Military Medical Academy, Serbia
Nermeen M. ElBakary, Egyptian atomic energy authority, Egypt
Ali Mehboob, Genesis Biotech Group LLC, USA
Asfar S. Azmi, Wayne State University, United States
Nguyen Dinh Song, Cho Ray Hospital, Vietnam

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in “2nd Edition of International Cancer Conference (ICC 2026)” during November 09-11, 2026. ICC 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.

Iris Scientific Group takes great pride in announcing the successful outcome of the Global Conference on Material Science and Nanotechnology (GCMN 2025) which was held in Virtual Mode from April 28-30, 2025.

For GCMN 2025 Final Program: Click Here

Organizing Committee of GCMN 2025:

Stanislav Ordin, Russian Academy of Sciences, Russia
Vladimir G. Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Paulo Cesar De Morais, Catholic University Of Brasilia, Brazil
Roya Dastjerdi, Yazd University, Iran

The Organizing Committee would like to thank the moderators Santoshi Misra, St. Ann's College for women, India for her contribution which ensued in the smooth functioning of the conference.

GCMN 2025 Keynote Speakers:

Stanislav Ordin, Russian Academy of Sciences, Russia
Vladimir G. Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Paulo Cesar De Morais, Catholic University Of Brasilia, Brazil
Roya Dastjerdi, Yazd University, Iran

GCMN 2025 Plenary Speakers:

Alexander G. Ramm, Kansas State University, USA

GCMN 2025 Speakers:

Arun Kumar Singh, Guru Ghasidas Vishwavidyalaya, India
Subash Chandra Mishra, India
Christopher Oluwatobi Adeogun, South China University of Technology, China
Naseem Ahmad, Kunsan National University, Korea, Republic of
Manojit De, Guru Gobind Singh Educational Society’s Technical Campus, India
Shabina Ali, Abdul Wali Khan University Mardan, Pakistan
Maryam Motallebi Aghgonbad, Urmia University, Iran, Islamic Republic of
Asmaa Reda Abd EL-Salam, Sadat City University, Egypt
Santoshi Misra, St. Ann's College for women, India
Sameena Bibi, Air University, Pakistan
Bilal Ahmad Reshi, Narsimha Reddy Engineering College, India
S.V.A.R.Sastry, Harcourt Butler Technical University, India
Suresh C Ameta, PAHER University, India
Andrey Belousov, Intensive Care Kharkiv National Medical University, Ukraine
Olaniyi Awe, Obafemi Awolowo University, Nigeria

GCMN 2025 Poster Presenters:

Dariusz Bochenek, University of Silesia in Katowice, Poland
Dagmara BrzeziÅ„ska, University of Silesia in Katowice, Poland

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in “2nd Global Conference on Material Science and Nanotechnology (GCMN 2026)” during April 13-15, 2026.

GCMN 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.

Media Partner